PRESENTATIONS & VIDEOS 2020

Proactive - Zelira Therapeutics forms exclusive licensing deal to distribute its HOPE products in Washington DC

18/12/2020

Proactive - Zelira Therapeutics and Emyria team up for 'disruptive' autism spectrum disorder trial

09/11/2020

Investor Presentation - Non-Deal Roadshow

22/10/2020

Presentation - ASX Small and Mid-Cap Conference

10/09/2020

Proactive - ASX Small and Mid-Cap Conference

09/09/2020

Proactive - CEO Investor Sessions

11/08/2020

Investor Presentation

8/07/2020
Investor Presentation - Logistics for Benzinga conference
1/06/2020

Investor Presentation - Non-deal Roadshow

1/05/2020

Investor Teleconference: Insomnia Trial Meets Primary and Secondary Endpoints

8/04/2020

Insomnia Phase 2 Clinical Trial Presentation

8/04/2020

Proactive Interview - Zelira Therapeutics releases interim data for Phase II clinical trial for insomnia

20/02/2020